Medical Mavericks: BioVie and Soligenix, the Leaders in Life Sciences

11 months ago
1
Neurodegeneration Liver Disease Alzheimer's Parkinson's Rare Diseases Photodynamic Therapy Cutaneous T-cell Lymphoma GI Disorders Inflammatory Diseases Vaccine Development and Clinical-stage Biopharmaceuticals

This week’s episode of the RedChip Money Report includes interviews with senior executives from BioVie (NASDAQ: BIVI) & Soligenix (Nasdaq: SNGX)

Loading comments...